PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmacy Department, Vall d\'Hebron Hospital Universitari, Vall d\'Hebron Barcelona Hospital Campus, Barcelona, Spain.\', \'Pharmacy Department. Hospital, Universitario \'12 de Octubre\', Research Institute 12 de Octubre (i+12, Madrid, Spain.\', \'Pediatric Infectious Diseases and Primary Immunodeficiencies Unit, Pediatrics Department, Vall d´hebron Hospital, Barcelona, Spain.\', \'Unit of perinatal medicine, Obstetric and Gynaecology Department, Hospital Universitario \'12 de Octubre\', Research Institute 12 de Octubre (i+12, Madrid, Spain.\', \'Department of Obstetrics and Gynecology, Vall d\'Hebron Hospital Universitari, Vall d\'Hebron Barcelona Hospital Campus, Barcelona, Spain.\', \'Department of Neonatology, Vall d\'Hebron Hospital Universitari, Vall d\'Hebron Barcelona Hospital Campus, Barcelona, Spain.\', \'Unit of Infectious Diseases, Hospital Universitario \'12 de Octubre\', Research Institute 12 de Octubre (i+12, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/jcpt.13394
?:hasPublicationType
?:journal
  • Journal of clinical pharmacy and therapeutics
is ?:pmid of
?:pmid
?:pmid
  • 33638257
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.722
?:rankingScore_hIndex
  • 61
is ?:relation_isRelatedTo_publication of
?:title
  • Safety of tocilizumab in COVID-19 pregnant women and their newborn: A retrospective study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33638257>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33638257>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all